Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis

PURPOSE: To investigate the impact of treatment time and patterns in inoperable stage III non-small cell lung cancer (NSCLC) following concurrent chemoradiotherapy (cCRT) ± immune checkpoint inhibitors (ICIs). METHODS: Patients were stratified by treatment year: A (2011–2014), B (2015–2017) and C (2...

Descripción completa

Detalles Bibliográficos
Autores principales: Flörsch, Benedikt, Taugner, Julian, Käsmann, Lukas, Kenndoff, Saskia, Guggenberger, Julian, Tufman, Amanda, Reinmuth, Niels, Duell, Thomas, Belka, Claus, Eze, Chukwuka, Manapov, Farkhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314870/
https://www.ncbi.nlm.nih.gov/pubmed/35915184
http://dx.doi.org/10.1007/s00432-022-04174-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314870/
https://www.ncbi.nlm.nih.gov/pubmed/35915184
http://dx.doi.org/10.1007/s00432-022-04174-z

Ejemplares similares